BlackRock Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.25M | Sell |
37,209
-7,255
| -16% | -$243K | ﹤0.01% | 1691 |
|
|
2016
Q3 | $1.18M | Sell |
44,464
-993
| -2% | -$26.4K | ﹤0.01% | 1685 |
|
|
2016
Q2 | $1M | Sell |
45,457
-5,062
| -10% | -$112K | ﹤0.01% | 1732 |
|
|
2016
Q1 | $1.48M | Buy |
50,519
+5,407
| +12% | +$159K | ﹤0.01% | 1530 |
|
|
2015
Q4 | $1.49M | Sell |
45,112
-8,246
| -15% | -$272K | ﹤0.01% | 1507 |
|
|
2015
Q3 | $1.93M | Sell |
53,358
-2,393
| -4% | -$86.5K | ﹤0.01% | 1355 |
|
|
2015
Q2 | $2.51M | Sell |
55,751
-29,353
| -34% | -$1.32M | ﹤0.01% | 1150 |
|
|
2015
Q1 | $2.61M | Buy |
85,104
+27,518
| +48% | +$843K | ﹤0.01% | 1103 |
|
|
2014
Q4 | $2.93M | Sell |
57,586
-12,644
| -18% | -$643K | ﹤0.01% | 1068 |
|
|
2014
Q3 | $2.78M | Buy |
70,230
+28,226
| +67% | +$1.12M | ﹤0.01% | 1069 |
|
|
2014
Q2 | $1.81M | Buy |
42,004
+40,051
| +2,051% | +$1.72M | ﹤0.01% | 1175 |
|
|
2014
Q1 | $78K | Buy |
1,953
+59
| +3% | +$2.36K | ﹤0.01% | 3107 |
|
|
2013
Q4 | $52K | Sell |
1,894
-79
| -4% | -$2.17K | ﹤0.01% | 3211 |
|
|
2013
Q3 | $45K | Sell |
1,973
-42,025
| -96% | -$959K | ﹤0.01% | 3201 |
|
|
2013
Q2 | $779K | Buy |
+43,998
| New | +$779K | ﹤0.01% | 1516 |
|